1Y Target$72.33Near-term target
5Y Target$120.96Compound horizon
10Y Target$314.76Long-dated conviction
FCF$758mTTM · 03/26C+FCF $758m — respectable but not differentiating · TTM computed from 4 most-recent quarters (TTM · 03/26).
Rev+8.6%TTM YoYBRevenue +8.6% — at or above S&P median
D/E1.28C+D/E 1.28 — moderately levered, watch interest coverage
P/S1.3xA-P/S 1.3x — cheap for any tech/growth name
PEG0.20APEG 0.20 — exceptional; paying well under fair value for growth
Why now
Chemicals · market cap $4.7b. 10% off the 52-week high of $66.75. PEG 0.20 — paying under fair value for the growth rate. 9 sell-side analysts publish a mean 1-yr target of $72.33 (implying +20% upside).
Moat
Speculative bucket — the moat thesis is forward-looking; without proven margin structure or capital efficiency yet, the durability argument is about IP / network effects / first-mover position that the company hasn't fully monetized.
Risk
Currently unprofitable (margin -1.2%) — path to GAAP profitability is the core thesis risk. ROE 1% is below the long-run sustainable threshold of ~10% — capital efficiency would need to improve for the equity base to compound at the market rate.
Horizon
1-3 yr $72.33 (9-analyst consensus) — catalyst-driven; binary events dominate. 5 yr $120.96 — requires the platform / technology to reach commercial scale. 10 yr $314.76 — return distribution heavily skewed.
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See
terms and
methodology for full disclosures.